Severe and disabling constipation: An adverse effect of pregabalin

doi:10.1111/j.1528-1167.2009.02381.x

Paper

Severe and disabling constipation: An adverse effect of pregabalin

Published Oct 20, 2009 · J. Kamel, W. D'Souza, M. Cook

Epilepsia

Q1 SJR score

16

Citations

2

Influential Citations

Full textSemantic Scholar

Abstract

The incidence of constipation as an adverse effect of pregabalin has previously been reported as low, with all cases described as either mild or moderate. From the experience of a tertiary referral epilepsy hospital center, we report several cases of severe and disabling constipation after initiating pregabalin, and resolving only on drug withdrawal. Of 80 consecutive patients, six (7.5%) developed significant constipation within 1–2 weeks of commencing pregabalin. Constipation was the most frequent adverse effect that required pregabalin to be withdrawn (6.3% of patients). The severity of symptoms was dose dependent. Pregabalin can cause marked constipation in some patients, and can lead to multiple unnecessary investigations and procedures if the clinician is not aware of this entirely reversible side effect.

Case Report

Study Snapshot

Pregabalin can cause severe and disabling constipation in some patients, requiring drug withdrawal, and this side effect is reversible.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Severe and disabling constipation: An adverse effect of pregabalin

Sign up to use Study Snapshot

References

Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial

Pregabalin 600 mg/d (300 mg BID) effectively reduced pain and was well-tolerated, but had no significant effect on nerve conduction in patients with painful diabetic peripheral neuropathy.

Immunostaining of rat brain, spinal cord, sensory neurons and skeletal muscle for calcium channel alpha2-delta (α2-δ) type 1 protein

Dense alpha2-delta-1 staining in brain and spinal cord regions suggests that pregabalin and gabapentin likely act as analgesic, anticonvulsant, and anxiolytic-like drugs in animal models.

Editor's quiz: Oesophagogastric fistula: a post-operative complication.

Pregabalin increases rectal distension sensory thresholds to normal levels in IBS patients with rectal hypersensitivity, while also increasing rectal compliance without affecting sensitivity.

Pregabalin: A New Neuromodulator with Broad Therapeutic Indications

Pregabalin is an effective and safe treatment option for neuropathic pain, partial epilepsy, and anxiety disorders, with common adverse effects being dizziness and somnolence.

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

Pregabalin effectively reduces chronic neuropathic pain and improves sleep interference, with optimal dosing balancing efficacy and tolerability.

Citations

Molecular mechanisms of cholinergic neurotransmission in visceral smooth muscles with a focus on receptor-operated TRPC4 channel and impairment of gastrointestinal motility by general anaesthetics and anxiolytics

Acetylcholine-induced membrane depolarization and smooth muscle contraction are mediated by the receptor-operated TRPC4 channel, which is also affected by general anesthetics and anxiolytics, impairing gastrointestinal motility.

Poo Matters! A scoping review of the impact of constipation on epilepsy

Constipation is a common co-morbid condition in people with epilepsy, and its relationship with epilepsy and anti-seizure medications requires further research.

Association between radicular low back pain and constipation: a retrospective cohort study using a real-world national database

Lumbar radiculopathy (LSR) does not significantly increase the odds of constipation compared to nonradicular low back pain, suggesting LSR is not a direct cause of constipation.

Hypercapnia Caused by a Therapeutic Dosage of Pregabalin in a Tetraplegic Patient With Cervical Spinal Cord Injury.

A therapeutic dose of pregabalin can cause CO2 retention in patients with cervical spinal cord injury, requiring tracheal intubation and ventilation.

Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician’s Overview

Commonly used antiepileptic drugs (AEDs) in adolescents and adults can cause side effects, reducing quality of life and increasing healthcare costs.

Pregabalin abuse for enhancing sexual performance: case discussion and literature review

Pregabalin abuse can enhance sexual desire and excitement, and its addictive potential should be considered when prescribing the medication for anxiety management.

Effects of pregabalin in patients with hypnotic-dependent insomnia.

Pregabalin may be a promising candidate for hypnotic withdrawal and improved sleep in patients with hypnotic-dependent insomnia, with side effects including nausea and dizziness.

Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study

Pregabalin is well-tolerated and well-tolerated when combined with specific psychotropic drugs, suggesting a stronger anxiolytic effect when combined with specific psychotropic drugs (e.g., SSRIs).